The shipment follows regulatory approvals for direct importation and positions AutoMax to begin marketing and sales activities for JAC Motors vehicles across Israel.

To maximize its cash runway while the Board conducts its review of strategic alternatives, Viracta has elected to close its ongoing pivotal Phase 2 clinical trial of Nana-val in relapsed/refractory ...

In May 2024, IsoPet ® was launched as a standalone division within Vivos Inc., reaffirming the company’s commitment to advancing veterinary cancer care. The division is led by a team of experienced ...

FREDERICK, Md., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announced ...

Additional information about the reverse stock split can be found in Optinose’s Definitive Proxy Statement filed with the Securities and Exchange Commission (“SEC”) on December 12, 2024. The Proxy ...

Portable, Travel-Friendly Device That Includes Everything You Need For On-The-Go Red Light Therapy. All Neatly Packed Into A ...

WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell ...

Vancouver, Canada, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and ...

Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.

Cette étude, menée par une équipe d’addictologues et de neurologues de l’Université du Texas révèle un effet bien particulier de l’alcool sur le cerveau : le trouble de la consommation d'alcool semble ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Des résultats de l’étude sur la polyarthrite rhumatoïde récemment conduite soulèvent des questions ...